Table 3.
parameter | β | SE | P | OR (95% CI) |
---|---|---|---|---|
Age | 0.064 | 0.020 | 0.001* | 1.066 (1.025~1.108) |
ECASS-II > 2 | −0.445 | 0.922 | 0.630 | 0.641 (0.105~3.908) |
MLS | 0.285 | 0.062 | <0.001* | 1.330(1.177~1.503) |
GLU | 0.132 | 0.085 | 0.121 | 1.141 (0.966~1.349) |
hs-CRPa | 0.129 | 0.151 | 0.393 | 1.138 (0.846~1.531) |
NLRa | 1.200 | 0.391 | 0.002* | 3.319 (1.542~7.144) |
*Statistically significant at p < 0.05 level, two-sided;
aThese variables were transformed into log scale.
ECASS-II European Cooperative Acute Stroke Study-II classification, MLS midline shift, GLU baseline blood glucose, hs-CRP high sensitivity C-reactive protein, NLR neutrophil to lymphocyte ratio, OR Odds Ratio, CI confidence Interval, SE standard error